Jong Joseph Kim - 11 Mar 2022 Form 4 Insider Report for INOVIO PHARMACEUTICALS, INC. (INO)

Signature
/s/ Jong Joseph Kim
Issuer symbol
INO
Transactions as of
11 Mar 2022
Net transactions value
-$127,828
Form type
4
Filing time
14 Mar 2022, 16:36:28 UTC
Previous filing
09 Mar 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction INO Common Stock Options Exercise +139,387 +11% 1,462,325 11 Mar 2022 Direct F1
transaction INO Common Stock Tax liability $127,828 -39,698 -2.7% $3.22* 1,422,627 11 Mar 2022 Direct F2
holding INO Common Stock 816,527 11 Mar 2022 By Family Limited Partnership
holding INO Common Stock 33,563 11 Mar 2022 By Daughter: EK
holding INO Common Stock 33,775 11 Mar 2022 By Son: JK1
holding INO Common Stock 5,975 11 Mar 2022 By Spouse
holding INO Common Stock 33,533 11 Mar 2022 By Son: JK2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INO Restricted Stock Unit Options Exercise $0 -139,387 -50% $0.000000 139,386 11 Mar 2022 Common Stock 139,387 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 418,160 restricted stock units is as follows: 139,387 shares vested on March 11, 2021; 139,387 shares vested on March 11, 2022; 139,386 shares will vest on March 11, 2023. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both.
F2 The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting and settlement of the restricted stock unit award reported in footnote (1) herein.